Breaking News
October 3, 2006
SAFC Pharma, a member of the Sigma-Aldrich Group, is expanding its cCMP protein purification capacity to meet market demand for therapeutic proteins from plant- and animal-sourced starting materials. When completed in April of 2007, the natural and r…
Read More »
October 3, 2006
Xanthus Pharmaceuticals, Inc. has licensed from Schering AG the exclusive right to develop and commercialize oral fludarabine in the U.S.
Oral fludarabine is currently marketed by Schering AG in the EU and Canada under the name, Fludara, for the tr…
Read More »
October 3, 2006
GlaxoSmithKline’s sNDA for its anticoagulant product Arixtra Injection has been accepted for priority review by the FDA. This application was based on positive results from two Phase III trials (OASIS 5 and 6) that evaluated Arixtra in the trea…
Read More »
